Press Releases for AMT

Press Releases
American Tower Corporation Reports Third Quarter 2009 Financial Results
BenchmarkJournal.Com Free Analyst Review for PVH, COH, AMT, CRM, CIM and APC
Amsterdam Molecular Therapeutics Reports Half Year Results 2009
American Tower Corporation Calls for Redemption of All Outstanding 3.00% Convertible Notes
American Tower Corporation Reports Second Quarter 2009 Financial Results
American Tower Corporation Announces Completion of Redemption of Outstanding 7.50% Senior Notes
American Tower Plans Second Quarter 2009 Earnings Release and Conference Call
American Tower Corporation Announces Completion of Tender Offer for 7.50% Senior Notes Due 2012
American Tower Corporation Calls for Redemption of All Outstanding 7.50% Senior Notes
Glybera(TM) Shows Long-Term Health Benefits
American Tower Announces Acceptance of Tendered 7.50% Senior Notes Due 2012
AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
American Tower Corporation Prices Senior Note Offering
American Tower Corporation Announces Offering of $300.0 Million Senior Notes
American Tower Corporation Announces Closing of XCEL Telecom Private Limited Acquisition
American Tower Corporation Announces Commencement of Cash Tender Offer for 7.50% Senior Notes Due 2012
American Tower to Speak at J.P. Morgan Global Technology, Media and Telecom Conference
AMT Starts Preregistration Trial for Glybera(TM)
MaybachFinancial.Com Posts Free Analyst Report on ALD, AMT, CB and CLF
American Tower Plans First Quarter 2009 Earnings Release and Conference Call
American Tower Names Thomas Bartlett as Chief Financial Officer
American Tower to Speak at Raymond James 30th Annual Institutional Investors Conference
American Tower Corporation Reports Fourth Quarter and Full Year 2008 Financial Results - Feb 27 2009 11:00AM
American Tower Corporation Reports Fourth Quarter and Full Year 2008 Financial Results - Feb 26 2009 6:19AM
Amsterdam Molecular Therapeutics Reports Full Year Results 2008
AMT to Release Full Year 2008 Results on February 24, 2009
Zacks Bull & Bear of the Day Highlights: American Tower, Marlin Business Services, RightNow Tech, Redhat and Progress Software
American Tower Plans Fourth Quarter and Full Year 2008 Earnings Release and Conference Call
AMT: Glybera(R) Lowers Pancreatitis Incidence Significantly
AMT CEO Ronald Lorijn Steps Down
American Tower to Speak at the Citi 19th Annual Entertainment, Media and Telecommunications Conference
Fitch: U.S. Telecom and Cable Credit Profiles to Weaken in 2009
Zacks Analyst Blog Highlights: BJ's Wholesale Club Inc., Double Eagle Petroleum Co., American Tower Corp., Vital Images, Inc. And Patterson-UTI Energy, Inc.
American Tower Corporation Reports Third Quarter 2008 Financial Results
American Tower Plans Third Quarter 2008 Earnings Release and Conference Call
AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R)
Zacks Bull and Bear of the Day Highlights: American Tower, General Motors, Investors Real Estate Trust, Napster and Ingram Micro - Sep 22 2008 5:15PM
AMT Obtains License to Amgen's GDNF Gene to Develop Treatment for Parkinson's Disease with AMT's Proprietary Gene Therapy Platform
American Tower to Speak at Goldman Sachs Communacopia Conference
Amsterdam Molecular Therapeutics Reports Half Year Results 2008
American Tower Corporation Announces Completion of Redemption of Outstanding 3.25% Convertible Notes
AMT to Release Half Year 2008 Results on August 13, 2008
Seven Summits Research Releases Comments on WMT, MS, MET, SPW, and AMT
American Tower Corporation Reports Second Quarter 2008 Financial Results
AMT Appoints Director Global Marketing and Sales
American Tower Corporation Calls for Redemption of All Outstanding 3.25% Convertible Notes
AMT Starts Collaboration With St. Jude Children's Research Hospital on Gene Therapy for Hemophilia B. Company Accesses Exclusive Commercial Rights to Final Therapy
American Tower Plans Second Quarter 2008 Earnings Release and Conference Call
AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
American Tower Announces Departure of CFO Brad Singer
AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
AMT Announces Positive Interim Clinical Data on its Lead Product AMT-011
AMT Announces Presentations During the 11th Annual Meeting of the ASGT
AMT's Cooperative Research and Development Agreement With NIH to Boost Production Capacity
American Tower to Speak at Lehman Brothers Worldwide Wireless and Wireline Conference - May 26 2008 10:33PM
AMT Accesses Technology for Treatment of Duchenne Muscular Dystrophy - May 27 2008 1:34AM
Seven Summits Research Releases Comments on EBAY, VZ, PTR, SYMC, and AMT - May 27 2008 1:17AM
American Tower Corporation Reports First Quarter 2008 Financial Results - Jun 1 2008 7:06AM
American Tower Plans First Quarter 2008 Earnings Release and Conference Call
Amsterdam Molecular Therapeutics Part of Next Biotech Index
Amsterdam Molecular Therapeutics to Appoint George Morstyn to Supervisory Board